Northwestern University
Broad Institute and Northwestern University researchers are encouraging others to examine noncoding genes, when investigating undiagnosed rare diseases.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
ASCO Data Bolster Talzenna, Xtandi Benefit in HRR-Mutant mCRPC as Pfizer Pursues Allcomers Approval
Premium
Biomarker-selected patients benefited from the added PARP inhibitor, but oncologists still don't know what to think about the benefit in patients without HRR mutations.
State-Regulated Illinois Health Plans Subject to Biomarker Test Coverage Mandate Starting 2022
Premium
The law requires state employee, Medicaid, public school, and small employer plans to cover evidence-based biomarker testing, a change that will readily impact cancer patients.
Oncologists See Clinical Trial Disruptions as Coronavirus Pandemic Continues
From changes in trial enrollment to increased flexibility, clinical trials in precision oncology and other fields are feeling the brunt of the ongoing COVID-19 pandemic.